In particular, AFP, a widely used biomarker in liver cancer diagnosis, has a sensitivity of only 62.4% at the diagnostic threshold of 20 ng/mL, rendering it insufficient for early detection and prone to false negatives.5 This evidence concerns the gene AFP and liver cancer.